Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03704051 · ClinicalTrials.gov registry record
Breast Versus Bottle Study
A clinical trial, sponsored by California Polytechnic State University-San Luis Obispo.
- Completed
- Registry status
- 94
- Enrollment target
NCT03704051: Completed study, sponsored by California Polytechnic State University-San Luis Obispo.
NCT03704051 is a clinical trial that has completed, run by California Polytechnic State University-San Luis Obispo. The registered enrollment target is 94 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03704051 has completed, sponsored by California Polytechnic State University-San Luis Obispo.
- COMPLETED
- Registry status
- 94 participants
- Enrollment target
Study Summary
The objective of the proposed research is to conduct a within-subject experimental study that will assess the effect of feeding mode (breast- versus bottle-feeding) on the quality and outcome of infant feeding interactions.
Primary Outcome
For both breast- and bottle-feedings, infant intake will be assessed by pre- and post-weighing the baby on an infant scale (model 374; Seca, Hamburg, Germany). During bottle-feedings, we will also note whether the infant finishes the bottle.
Interventions
- BEHAVIORAL Mode of Feeding (breastfeeding versus bottle-feeding)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2018-10-15 |
| Est. Completion | 2021-07-01 |
What the finished NCT03704051 record still lists
NCT03704051 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 94 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Mode of Feeding (breastfeeding versus bottle-feeding) is the first listed.
NCT03704051 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03704051 about?
NCT03704051 is a clinical study titled "Breast Versus Bottle Study". The objective of the proposed research is to conduct a within-subject experimental study that will assess the effect of feeding mode (breast- versus bottle-feeding) on the quality and outcome of infant feeding interactions.
What is the current status of trial NCT03704051?
This trial is currently completed. The enrollment target is 94 participants. The study started on 2018-10-15. Estimated completion is 2021-07-01.
What interventions are being tested in trial NCT03704051?
The interventions under investigation include: Mode of Feeding (breastfeeding versus bottle-feeding) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03704051?
This trial is sponsored by California Polytechnic State University-San Luis Obispo, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03747146 · 94 participants · NA
Enhanced Recovery After Surgery (ERAS) Total Knee Replacement (TKR) With a Transitional Pain Service
- NCT04061421 · 94 participants · Phase 1
Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)
- NCT04205968 · 94 participants · Phase 2
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
- NCT04464759 · 94 participants · Phase 1
A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI